B-intervention	0	8	Regional
I-intervention	9	14	Nodal
I-intervention	15	26	Irradiation
O	27	29	in
O	30	35	Early
O	35	36	-
O	36	41	Stage
O	42	48	Breast
O	49	55	Cancer
O	55	56	.

O	57	61	Most
O	62	67	women
O	68	72	with
O	73	79	breast
O	80	86	cancer
O	87	90	who
O	91	98	undergo
O	99	105	breast
O	105	106	-
O	106	116	conserving
O	117	124	surgery
O	125	132	receive
O	133	138	whole
O	138	139	-
O	139	145	breast
O	146	157	irradiation
O	157	158	.

O	159	161	We
O	162	170	examined
O	171	178	whether
O	179	182	the
O	183	191	addition
O	192	194	of
O	195	203	regional
O	204	209	nodal
O	210	221	irradiation
O	222	224	to
O	225	230	whole
O	230	231	-
O	231	237	breast
O	238	249	irradiation
O	250	258	improved
O	259	267	outcomes
O	267	268	.

O	269	271	We
O	272	280	randomly
O	281	289	assigned
B-eligibility	290	295	women
I-eligibility	296	300	with
I-eligibility	301	305	node
I-eligibility	305	306	-
I-eligibility	306	314	positive
I-eligibility	315	317	or
I-eligibility	318	322	high
I-eligibility	322	323	-
I-eligibility	323	327	risk
I-eligibility	328	332	node
I-eligibility	332	333	-
I-eligibility	333	341	negative
I-eligibility	342	348	breast
I-eligibility	349	355	cancer
I-eligibility	356	359	who
I-eligibility	360	364	were
I-eligibility	365	372	treated
I-eligibility	373	377	with
I-eligibility	378	384	breast
I-eligibility	384	385	-
I-eligibility	385	395	conserving
I-eligibility	396	403	surgery
I-eligibility	404	407	and
I-eligibility	408	416	adjuvant
I-eligibility	417	425	systemic
I-eligibility	426	433	therapy
O	434	436	to
O	437	444	undergo
O	445	451	either
O	452	457	whole
O	457	458	-
O	458	464	breast
O	465	476	irradiation
O	477	481	plus
O	482	490	regional
O	491	496	nodal
O	497	508	irradiation
O	509	510	(
O	510	519	including
O	520	528	internal
O	529	536	mammary
O	536	537	,
O	538	553	supraclavicular
O	553	554	,
O	555	558	and
O	559	567	axillary
O	568	573	lymph
O	574	579	nodes
O	579	580	)
O	581	582	(
O	582	587	nodal
O	587	588	-
O	588	599	irradiation
O	600	605	group
O	605	606	)
O	607	609	or
B-control	610	615	whole
I-control	615	616	-
I-control	616	622	breast
I-control	623	634	irradiation
I-control	635	640	alone
I-control	641	642	(
I-control	642	649	control
I-control	650	655	group
I-control	655	656	)
O	656	657	.

O	658	661	The
O	662	669	primary
O	670	677	outcome
O	678	681	was
B-outcome-Measure	682	689	overall
I-outcome-Measure	690	698	survival
O	698	699	.

O	700	709	Secondary
O	710	718	outcomes
O	719	723	were
B-outcome-Measure	724	731	disease
I-outcome-Measure	731	732	-
I-outcome-Measure	732	736	free
I-outcome-Measure	737	745	survival
O	745	746	,
B-outcome-Measure	747	755	isolated
I-outcome-Measure	756	768	locoregional
I-outcome-Measure	769	776	disease
I-outcome-Measure	776	777	-
I-outcome-Measure	777	781	free
I-outcome-Measure	782	790	survival
O	790	791	,
O	792	795	and
B-outcome-Measure	796	803	distant
I-outcome-Measure	804	811	disease
I-outcome-Measure	811	812	-
I-outcome-Measure	812	816	free
I-outcome-Measure	817	825	survival
O	825	826	.

O	827	834	Between
O	835	840	March
O	841	845	2000
O	846	849	and
O	850	858	February
O	859	863	2007
O	863	864	,
O	865	866	a
O	867	872	total
O	873	875	of
B-intervention-participants	876	880	1832
O	881	886	women
O	887	891	were
O	892	900	assigned
O	901	903	to
O	904	907	the
O	908	913	nodal
O	913	914	-
O	914	925	irradiation
O	926	931	group
O	932	934	or
O	935	938	the
O	939	946	control
O	947	952	group
O	953	954	(
B-control-participants	954	957	916
O	958	963	women
O	964	966	in
O	967	971	each
O	972	977	group
O	977	978	)
O	978	979	.

O	980	983	The
O	984	990	median
O	991	997	follow
O	997	998	-
O	998	1000	up
O	1001	1004	was
O	1005	1006	9
O	1006	1007	.
O	1007	1008	5
O	1009	1014	years
O	1014	1015	.

O	1016	1018	At
O	1019	1022	the
O	1023	1025	10
O	1025	1026	-
O	1026	1030	year
O	1031	1037	follow
O	1037	1038	-
O	1038	1040	up
O	1040	1041	,
O	1042	1047	there
O	1048	1051	was
O	1052	1054	no
O	1055	1066	significant
O	1067	1074	between
O	1074	1075	-
O	1075	1080	group
O	1081	1091	difference
O	1092	1094	in
B-outcome	1095	1103	survival
O	1103	1104	,
O	1105	1109	with
O	1110	1111	a
O	1112	1116	rate
O	1117	1119	of
B-iv-bin-percent	1120	1122	82
I-iv-bin-percent	1122	1123	.
I-iv-bin-percent	1123	1124	8
I-iv-bin-percent	1124	1125	%
O	1126	1128	in
O	1129	1132	the
O	1133	1138	nodal
O	1138	1139	-
O	1139	1150	irradiation
O	1151	1156	group
O	1157	1160	and
B-cv-bin-percent	1161	1163	81
I-cv-bin-percent	1163	1164	.
I-cv-bin-percent	1164	1165	8
I-cv-bin-percent	1165	1166	%
O	1167	1169	in
O	1170	1173	the
O	1174	1181	control
O	1182	1187	group
O	1188	1189	(
O	1189	1195	hazard
O	1196	1201	ratio
O	1201	1202	,
O	1203	1204	0
O	1204	1205	.
O	1205	1207	91
O	1207	1208	;
O	1209	1211	95
O	1211	1212	%
O	1213	1223	confidence
O	1224	1232	interval
O	1233	1234	[
O	1234	1236	CI
O	1236	1237	]
O	1237	1238	,
O	1239	1240	0
O	1240	1241	.
O	1241	1243	72
O	1244	1246	to
O	1247	1248	1
O	1248	1249	.
O	1249	1251	13
O	1251	1252	;
O	1253	1254	P
O	1254	1255	=
O	1255	1256	0
O	1256	1257	.
O	1257	1259	38
O	1259	1260	)
O	1260	1261	.

O	1262	1265	The
B-outcome	1266	1271	rates
I-outcome	1272	1274	of
I-outcome	1275	1282	disease
I-outcome	1282	1283	-
I-outcome	1283	1287	free
I-outcome	1288	1296	survival
O	1297	1301	were
B-iv-bin-percent	1302	1304	82
I-iv-bin-percent	1304	1305	.
I-iv-bin-percent	1305	1306	0
I-iv-bin-percent	1306	1307	%
O	1308	1310	in
O	1311	1314	the
O	1315	1320	nodal
O	1320	1321	-
O	1321	1332	irradiation
O	1333	1338	group
O	1339	1342	and
B-cv-bin-percent	1343	1345	77
I-cv-bin-percent	1345	1346	.
I-cv-bin-percent	1346	1347	0
I-cv-bin-percent	1347	1348	%
O	1349	1351	in
O	1352	1355	the
O	1356	1363	control
O	1364	1369	group
O	1370	1371	(
O	1371	1377	hazard
O	1378	1383	ratio
O	1383	1384	,
O	1385	1386	0
O	1386	1387	.
O	1387	1389	76
O	1389	1390	;
O	1391	1393	95
O	1393	1394	%
O	1395	1397	CI
O	1397	1398	,
O	1399	1400	0
O	1400	1401	.
O	1401	1403	61
O	1404	1406	to
O	1407	1408	0
O	1408	1409	.
O	1409	1411	94
O	1411	1412	;
O	1413	1414	P
O	1414	1415	=
O	1415	1416	0
O	1416	1417	.
O	1417	1419	01
O	1419	1420	)
O	1420	1421	.

O	1422	1430	Patients
O	1431	1433	in
O	1434	1437	the
O	1438	1443	nodal
O	1443	1444	-
O	1444	1455	irradiation
O	1456	1461	group
O	1462	1465	had
O	1466	1472	higher
O	1473	1478	rates
O	1479	1481	of
B-outcome	1482	1487	grade
I-outcome	1488	1489	2
I-outcome	1490	1492	or
I-outcome	1493	1500	greater
I-outcome	1501	1506	acute
I-outcome	1507	1518	pneumonitis
O	1519	1520	(
B-iv-bin-percent	1520	1521	1
I-iv-bin-percent	1521	1522	.
I-iv-bin-percent	1522	1523	2
I-iv-bin-percent	1523	1524	%
O	1525	1527	vs
O	1527	1528	.
B-cv-bin-percent	1529	1530	0
I-cv-bin-percent	1530	1531	.
I-cv-bin-percent	1531	1532	2
I-cv-bin-percent	1532	1533	%
O	1533	1534	,
O	1535	1536	P
O	1536	1537	=
O	1537	1538	0
O	1538	1539	.
O	1539	1541	01
O	1541	1542	)
O	1543	1546	and
B-outcome	1547	1557	lymphedema
O	1558	1559	(
B-iv-bin-percent	1559	1560	8
I-iv-bin-percent	1560	1561	.
I-iv-bin-percent	1561	1562	4
I-iv-bin-percent	1562	1563	%
O	1564	1566	vs
O	1566	1567	.
B-cv-bin-percent	1568	1569	4
I-cv-bin-percent	1569	1570	.
I-cv-bin-percent	1570	1571	5
I-cv-bin-percent	1571	1572	%
O	1572	1573	,
O	1574	1575	P
O	1575	1576	=
O	1576	1577	0
O	1577	1578	.
O	1578	1581	001
O	1581	1582	)
O	1582	1583	.

O	1584	1589	Among
O	1590	1595	women
O	1596	1600	with
O	1601	1605	node
O	1605	1606	-
O	1606	1614	positive
O	1615	1617	or
O	1618	1622	high
O	1622	1623	-
O	1623	1627	risk
O	1628	1632	node
O	1632	1633	-
O	1633	1641	negative
O	1642	1648	breast
O	1649	1655	cancer
O	1655	1656	,
O	1657	1660	the
O	1661	1669	addition
O	1670	1672	of
O	1673	1681	regional
O	1682	1687	nodal
O	1688	1699	irradiation
O	1700	1702	to
O	1703	1708	whole
O	1708	1709	-
O	1709	1715	breast
O	1716	1727	irradiation
O	1728	1731	did
O	1732	1735	not
O	1736	1743	improve
O	1744	1751	overall
O	1752	1760	survival
O	1761	1764	but
O	1765	1772	reduced
O	1773	1776	the
O	1777	1781	rate
O	1782	1784	of
O	1785	1791	breast
O	1791	1792	-
O	1792	1798	cancer
O	1799	1809	recurrence
O	1809	1810	.

O	1811	1812	(
O	1812	1818	Funded
O	1819	1821	by
O	1822	1825	the
O	1826	1834	Canadian
O	1835	1841	Cancer
O	1842	1849	Society
O	1850	1858	Research
O	1859	1868	Institute
O	1869	1872	and
O	1873	1879	others
O	1879	1880	;
O	1881	1883	MA
O	1883	1884	.
O	1884	1886	20
O	1887	1901	ClinicalTrials
O	1901	1902	.
O	1902	1905	gov
O	1906	1912	number
O	1912	1913	,
O	1914	1925	NCT00005957
O	1925	1926	.
O	1926	1927	)
O	1927	1928	.
